Evaluation of the revised criteria for biological and clinical staging of Alzheimer's disease

In this study we validated the new AD staging criteria and found that co-pathologies play an important role in symptom severity in individuals harboring less tau tangle pathology than expected for their clinical impairment. These results highlight the importance of measuring non-AD biomarkers in patients with worse cognitive impairment than expected based on their biological stage, which could impact clinical diagnosis and prognosis.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70856_098208
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of the revised criteria for biological and clinical staging of Alzheimer's disease

Piero Parchi, Rik Ossenkoppele, Erik Stomrud, Pontus Tideman et al.
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Evaluation of the revised criteria for biological and clinical staging of Alzheimer's disease

Piero Parchi, Rik Ossenkoppele, Erik Stomrud, Pontus Tideman, Gemma Salvadó, Danielle van Westen, Kaj Blennow, Colin Groot, Oskar H. Hansson, Alexa Pichet Binette, Henrik Zetterberg, Sebastian Palmqvist, Isabelle Glans, Niklas Mattsson‐Carlgren, Shorena Janelidze, Ruben Smith
article en

Abstract

In this study we validated the new AD staging criteria and found that co-pathologies play an important role in symptom severity in individuals harboring less tau tangle pathology than expected for their clinical impairment. These results highlight the importance of measuring non-AD biomarkers in patients with worse cognitive impairment than expected based on their biological stage, which could impact clinical diagnosis and prognosis.

Alzheimer s & DementiaVol. 21(S2)
University of Wisconsin–Madison (US), Lund University (SE), Hong Kong Science and Technology Parks Corporation (HK), Sahlgrenska University Hospital (SE), Sorbonne Université (FR), Profu (Sweden) (SE), Pasqual Maragall Foundation (ES), Institut de Myologie (FR), Pitié-Salpêtrière Hospital (FR), Istituto delle Scienze Neurologiche di Bologna (IT), Institut Universitaire de Gériatrie de Montréal (CA), Barcelonaβeta Brain Research Center (ES), Skåne University Hospital (SE), Wisconsin Division of Public Health (US), Amsterdam University Medical Centers (NL), Institut du Cerveau (FR), Istituti di Ricovero e Cura a Carattere Scientifico (IT), University College London (GB), Université de Montréal (CA), Vrije Universiteit Amsterdam (NL), University of Gothenburg (SE), University of Bologna (IT)
Openalex Percentile: Top 34%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.